PTMA and lung carcinoma: LINC00152 knockdown inhibits the proliferation, invasion, and migration of lung cancer cells through the EGFR/PI3K/AKT pathway, and improves apoptosis and the G1 phase ratio (14).Silencing LINC00152 enhanced the radiosensitivity of NSCLC cells by upregulating miR-206 and inhibiting prothymosin alpha (PTMA).